The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation

Alok A. Khorana; Keith McCrae; Dejan Milentijevic; Nora McCormick; François Laliberté; Concetta Crivera; Patrick Lefebvre; Dominique Lejeune; Heather Rozjabek; Jeff Schein; Michael B. Streiff

doi:10.1002/ajh.25361

The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation

Alok A. Khorana, Keith McCrae, Dejan Milentijevic, Nora McCormick, François Laliberté, Concetta Crivera, Patrick Lefebvre, Dominique Lejeune, Heather Rozjabek, Jeff Schein, Michael B. Streiff

School of Medicine

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	E58-E61
Journal	American journal of hematology
Volume	94
Issue number	2
DOIs	https://doi.org/10.1002/ajh.25361
State	Published - Feb 2019

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.25361

Cite this

Khorana, A. A., McCrae, K., Milentijevic, D., McCormick, N., Laliberté, F., Crivera, C., Lefebvre, P., Lejeune, D., Rozjabek, H., Schein, J., & Streiff, M. B. (2019). The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation. American journal of hematology, 94(2), E58-E61. https://doi.org/10.1002/ajh.25361

Khorana, AA, McCrae, K, Milentijevic, D, McCormick, N, Laliberté, F, Crivera, C, Lefebvre, P, Lejeune, D, Rozjabek, H, Schein, J & Streiff, MB 2019, 'The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation', American journal of hematology, vol. 94, no. 2, pp. E58-E61. https://doi.org/10.1002/ajh.25361

@article{12518578b21c4db684efb68e36aab3b7,

title = "The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation",

author = "Khorana, {Alok A.} and Keith McCrae and Dejan Milentijevic and Nora McCormick and Fran{\c c}ois Lalibert{\'e} and Concetta Crivera and Patrick Lefebvre and Dominique Lejeune and Heather Rozjabek and Jeff Schein and Streiff, {Michael B.}",

year = "2019",

month = feb,

doi = "10.1002/ajh.25361",

language = "English (US)",

volume = "94",

pages = "E58--E61",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "2",

}

TY - JOUR

T1 - The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation

AU - Khorana, Alok A.

AU - McCrae, Keith

AU - Milentijevic, Dejan

AU - McCormick, Nora

AU - Laliberté, François

AU - Crivera, Concetta

AU - Lefebvre, Patrick

AU - Lejeune, Dominique

AU - Rozjabek, Heather

AU - Schein, Jeff

AU - Streiff, Michael B.

PY - 2019/2

Y1 - 2019/2

UR - http://www.scopus.com/inward/record.url?scp=85058714237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058714237&partnerID=8YFLogxK

U2 - 10.1002/ajh.25361

DO - 10.1002/ajh.25361

M3 - Letter

C2 - 30474161

AN - SCOPUS:85058714237

SN - 0361-8609

VL - 94

SP - E58-E61

JO - American journal of hematology

JF - American journal of hematology

IS - 2

ER -

The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this